Hodgson R, An V, Stupart D A, Guest G D, Watters D A K
Department of Surgery, Barwon Health, Geelong, Australia; Department of Surgery, University of Melbourne, Austin Health, Heidelberg, Australia.
Department of Surgery, Barwon Health, Geelong, Australia.
Surgeon. 2016 Aug;14(4):184-9. doi: 10.1016/j.surge.2014.11.001. Epub 2015 Jan 24.
Many patients who undergo a Hartmann's procedure do not have their stoma reversed. We analysed parameters and co-morbidity scales to assess their accuracy in predicting likelihood of undergoing reversal.
Retrospective analysis of 165 patients from a prospective colorectal database who were discharged home following a Hartmann's procedure at Barwon Health (Geelong, Australia), a regional centre, between 2002 and 2010. Parameters measured included age, sex, time to reversal, ICU admission and pathology results were recorded. Patients' ASA, POSSUM and Elixhauser co-morbidity scales were retrospectively analysed.
Reversal of Hartmann's was performed in 74/165 (45%) patients after a median of 294 days (range 70-902). Age (mean 58.5 vs 72.9 years, p < 0.001), ICU stay (34/74 vs 66/91, p < 0.001), ASA (p < 0.002), Elixhauser co-morbidity count (mean 1.14 vs 1.92, p < 0.002) and a malignant diagnosis (9/74 vs 31/91, p < 0.002) were all associated with a decreased reversal rate on univariate analysis. Age was the only parameter found to be significant on multivariate analysis. The complication rate was 23/74, with 7/74 noted to have major complications (Clavian-Dindo III-IV). Reasons for not reversing patients included age and co-morbidities, patient refusal, and malignant disease progression.
More than half the patients undergoing a Hartmann's procedure did not proceed to a closure of their stoma. Age was the only parameter significant in predicting those patients undergoing reversal.
许多接受哈特曼手术的患者并未进行造口还纳。我们分析了各项参数及共病量表,以评估它们在预测造口还纳可能性方面的准确性。
对2002年至2010年间在澳大利亚吉朗地区中心医院巴旺健康中心接受哈特曼手术后出院回家的165例患者进行回顾性分析,这些患者的数据来自一个前瞻性结直肠数据库。记录测量的参数包括年龄、性别、还纳时间、入住重症监护病房情况及病理结果。对患者的美国麻醉医师协会(ASA)、手术风险评分系统(POSSUM)及埃利克斯豪泽共病量表进行回顾性分析。
165例患者中有74例(45%)在中位时间294天(范围70 - 902天)后进行了哈特曼造口还纳。单因素分析显示,年龄(平均58.5岁对72.9岁,p < 0.001)、入住重症监护病房情况(34/74对66/91,p < 0.001)、ASA评分(p < 0.002)、埃利克斯豪泽共病计数(平均1.14对1.92,p < 0.002)以及恶性诊断(9/74对31/91,p < 0.002)均与还纳率降低相关。多因素分析发现年龄是唯一具有显著意义的参数。并发症发生率为23/74,其中7/74发生了严重并发症(Clavian-Dindo III - IV级)。未进行造口还纳的原因包括年龄和共病情况、患者拒绝以及恶性疾病进展。
超过半数接受哈特曼手术的患者未进行造口关闭。年龄是预测哪些患者会进行造口还纳的唯一显著参数。